U.S., Nov. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07241715) titled 'Conversion Surgery for Gastric Cancer With Peritoneal Metastases (CONVERGENCE)' on Oct. 07, 2024.
Brief Summary: The goal of this clinical trial is to evaluate the impact of conversion surgery on overall survival (OS) in patients with gastric cancer peritoneal metastases (GCPM) who show a good response to preoperative systemic therapy (including first-line chemotherapy with or without targeted therapy and/or immunotherapy) with or without peritoneal-directed chemotherapy.]. The main question it aims to answer is:
(i) Will Conversion surgery be associated with improved overall survival (OS) in patients with GCPM who respond well to ...